IL-10⁺CD19⁺ regulatory B cells induce CD4⁺Foxp3⁺regulatory T cells in serum of cervical cancer patients

References

• Dumauthioz N, Labiano S, Romero P. Tumor resident memory T cells: new players in immune surveillance and therapy. Front Immunol. 2018;9:1.
   PubMed Web of Science ®Google Scholar
• Terren I, Orrantia A, Vitalle J, et al. NK cell metabolism and tumor microenvironment. Front Immunol. 2019;10:2278.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–8.
   PubMed Web of Science ®Google Scholar
• St PM, Ohashi PS. The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30(9):695–704.
   PubMed Web of Science ®Google Scholar
• Kelliher MA, Roderick JE. NOTCH signaling in T-cell-mediated anti-tumor immunity and T-cell-Based immunotherapies. Front Immunol. 2018;9:1718.
   PubMed Web of Science ®Google Scholar
• Demaria O, Cornen S, Daeron M, et al. Harnessing innate immunity in cancer therapy. NATURE. 2019;574(7776):45–56.
   PubMed Web of Science ®Google Scholar
• Zur HH. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350.
   PubMed Web of Science ®Google Scholar
• Ma Q, Zhao M, Wei X, et al. Expressions of immune negative regulator FoxP3 + treg and PD-L1 protein in the immune microenvironment of cervical lesion. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39:128–132.
   PubMedGoogle Scholar
• Ma Z, Zhang E, Gao S, et al. Toward a functional cure for hepatitis B: the rationale and challenges for therapeutic targeting of the B cell immune response. Front Immunol. 2019;10:2308.
   PubMed Web of Science ®Google Scholar
• Eibel H, Kraus H, Sic H, et al. B cell biology: an overview. Curr Allergy Asthm R. 2014;14:434.
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. IMMUNITY. 2015;42(4):607–612.
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30(1):221–241.
   PubMedGoogle Scholar
• Catalan D, Mansilla MA, Ferrier A, et al. Immunosuppressive mechanisms of regulatory B cells. Front Immunol. 2021;12:611795.
   PubMed Web of Science ®Google Scholar
• Wang Z, Cheng Q, Tang K, et al. Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (breg) cells. Cancer Lett. 2015;364(2):118–124.
   PubMed Web of Science ®Google Scholar
• Hu H, Ai X, Lu M, et al. Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer. Exp Cell Res. 2019;384(2):111652.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang L, Jia S, et al. Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma. Int Immunopharmacol. 2021;100:108161.
   PubMed Web of Science ®Google Scholar
• Manna A, Kellett T, Aulakh S, et al. Targeting CD38 is lethal to breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses. Blood Adv. 2020;4(10):2143–2157.
   PubMed Web of Science ®Google Scholar
• Alaqla A, Hu Y, Huang S, et al. TLR9 signaling is required for the porphyromonas gingivalis -induced activation of IL-10-expressing B cells. Int J Mol Sci. 2023;24(7):6693.
   PubMed Web of Science ®Google Scholar
• Lv Y, Tian W, Teng Y, et al. Tumor-infiltrating mast cells stimulate ICOS(+) regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression. J Adv Res. 2023;S2090-1232(23)00119-4.
   Google Scholar
• Heeren AM, de Boer E, Bleeker MC, et al. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area. Oncotarget. 2015;6(32):32484–32493.
   PubMedGoogle Scholar
• Das D, Sarkar B, Mukhopadhyay S, et al. An altered ratio of CD4+ and CD8+ T lymphocytes in cervical cancer tissues and peripheral blood – a prognostic clue? Asian Pacific Journal of Cancer Prevention: APJCP. 2018;19:471–478.
   PubMedGoogle Scholar
• Spinillo A, Dominoni M, Boschi AC, et al. Clinical significance of the interaction between human papillomavirus (HPV) type 16 and other high-risk human papillomaviruses in women with cervical intraepithelial neoplasia (CIN) and invasive cervical cancer. J Oncol. 2020;2020:6508180–6508189.
   PubMed Web of Science ®Google Scholar
• McClymont E, Lee M, Elwood C, et al. Cervical cancer screening in immunocompromised women. J Obstet Gynaecol Can. 2019;41(8):1177–1180.
   PubMed Web of Science ®Google Scholar
• Ouyang FZ, Wu RQ, Wei Y, et al. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma. Nat Commun. 2016;7(1):13453.
   PubMedGoogle Scholar
• Xiao X, Lao XM, Chen MM, et al. PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression. Cancer Discov. 2016;6(5):546–559.
   PubMed Web of Science ®Google Scholar
• Shao Y, Lo CM, Ling CC, et al. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett. 2014;355(2):264–272.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tai Y, Ho M, et al. Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu. Blood Cancer J. 2017;7(3):e547-e547.
   Google Scholar
• Zhao Z, Chen X, Hao S, et al. Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer. CYTOKINE. 2017;89:76–81.
   PubMed Web of Science ®Google Scholar
• Zhou X, Su YX, Lao XM, et al. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol. 2016;53:27–35.
   PubMed Web of Science ®Google Scholar
• Li Y, An J, Huang S, et al. Esophageal cancer-derived microvesicles induce regulatory B cells. Cell Biochem Funct. 2015;33(5):308–313.
   PubMed Web of Science ®Google Scholar
• Mao FY, Kong H, Zhao YL, et al. Increased tumor-infiltrating CD45RA(-)CCR7(-) regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress. Cell Death Dis. 2017;8(8):e3002–e3002.
   PubMedGoogle Scholar